Here’s What TD Cowen Thinks About Tempus AI Inc (TEM) Stock

According to TD Cowen, Tempus’ Insights concern is well-positioned for accelerated maturation and forecast bushed successful 2026. The steadfast besides expects continued maturation successful Tempus’ Genomics business. Tempus’ gross accrued 83.4% to $1.3 cardinal successful 2025. The institution is anticipating 2026 gross to beryllium $1.59 billion, implying a maturation of 25%.

The Tempus-SoftBank pact, unveiled successful June 2024, is structured arsenic a associated task and involves Tempus bringing its AI-driven attraction and objective proceedings recommendations to the Japanese market.

Japan’s AI successful healthcare marketplace size is forecast to scope $2.29 cardinal by 2034 from $545.3 cardinal successful 2025, according to IMARC Group estimates. Factors similar the expanding request for personalized medication, increasing involvement successful distant diligent monitoring, and the increasing request to accurately forecast diligent results are driving the marketplace growth.

Tempus AI Inc (NASDAQ:TEM), based successful Chicago, Illinois, offers precision medicine services. It makes usage of information and artificial quality for this work. Although the institution is chiefly focused connected crab treatment, it’s expanding into areas similar cardiology and infectious diseases. Tempus AI was founded successful 2015 by billionaire Eric Lefkofsky.

While we admit the imaginable of TEM arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: David Abrams’ Hedge Fund Is Betting On These 8 Stocks and 10 Best Energy Storage Stocks to Buy According to Hedge Funds.

Disclosure: None. Follow Insider Monkey connected Google News.